Medication info
Tops Tablets 80/5 mg

Tops Tablets 80/5 mg

Prescription medicationOral
Ingredient · strength
Telmisartan›80mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
Ildong Pharmaceutical Co., Ltd.
Appearance
This medicine is a white and light blue, double-sided, convex oval tablet.
Packaging
30 tablets/box [10 tablets/Alu-Alu)x3], 30 tablets/bottle
Approval status
Active

MFDS item code 201605613 · Approved 2016.09.22 · Insurance code 642905760

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before starting this medicine. However, if blood pressure is not controlled with the individual components as described below, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.
Child dose
○ Pediatric patients: Use of this medicine is not recommended in pediatric patients aged 18 years or younger because its safety and efficacy have not been established.

Ingredients

Manufacturer
Ildong Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used for patients with essential hypertension whose blood pressure is not well controlled with monotherapy of telmisartan or amlodipine. In other words, this medicine helps to effectively lower and manage blood pressure when monotherapy is insufficient to achieve adequate blood pressure control. This reduces the risk of cardiovascular complications and improves patients' health.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before starting this medicine. However, if blood pressure is not controlled with the individual components as described below, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.

Child dose

○ Pediatric patients: Use of this medicine is not recommended in pediatric patients aged 18 years or younger because its safety and efficacy have not been established.

Precautions

This medication should not be used during pregnancy, especially in the second and third trimesters, as it can pose a serious risk to the fetus. If pregnancy is confirmed, treatment with this medication should be discontinued as soon as possible. This medication is contraindicated for individuals allergic to certain components, pregnant women or those who may become pregnant, lactating women, and those with severe liver or heart problems. Additionally, it should not be given to patients with severe hypotension or in shock, or those who are unstable after an acute myocardial infarction. Caution is advised in administering this medication to some patients, such as those with impaired liver function, valvular heart disease, reduced kidney function, or elderly individuals. Side effects such as dizziness or swelling may occur frequently during treatment, so caution is necessary. While serious side effects are rare, any unusual symptoms should prompt immediate consultation with healthcare professionals. Because this medication lowers blood pressure, if symptoms of hypotension occur, the patient should be laid down, and intravenous fluids may be administered if necessary. This drug can also increase potassium levels, so periodic monitoring of serum potassium levels is required. Potential interactions may occur with other medications, therefore any concurrent medications should be disclosed to a doctor or pharmacist. This medication is not recommended for children as its safety and efficacy have not been sufficiently established. For elderly patients, dose adjustments and careful monitoring are required. In case of overdose, symptoms such as hypotension, dizziness, and heart rate changes may occur, requiring immediate medical attention. This medication should be kept out of reach of children and stored in a dry place, avoiding transfer to other containers.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 101 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • mood changes
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • sensory disturbance
  • sensory loss
  • taste disturbance
  • tremor
  • extrapyramidal disorder
  • muscle rigidity
  • visual impairment
  • double vision
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • shortness of breath
  • rhinitis
  • change in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gum enlargement
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver dysfunction
  • hepatic impairment
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • hair loss
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramp
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal dysfunction
  • urinary disorders
  • increased urination
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • elevated liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased serum uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • intestinal vascular edema

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and must be stored in a special container that prevents light exposure. Additionally, the medication should be stored at room temperature between 1 and 30 degrees Celsius to maintain effectiveness.

Appearance and packaging

Appearance

This medicine is a white and light blue, double-sided, convex oval tablet.

Package unit

30 tablets/box [10 tablets/Alu-Alu)x3], 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.